TW200528123A - Lipase inhibitor - Google Patents
Lipase inhibitor Download PDFInfo
- Publication number
- TW200528123A TW200528123A TW093138957A TW93138957A TW200528123A TW 200528123 A TW200528123 A TW 200528123A TW 093138957 A TW093138957 A TW 093138957A TW 93138957 A TW93138957 A TW 93138957A TW 200528123 A TW200528123 A TW 200528123A
- Authority
- TW
- Taiwan
- Prior art keywords
- fruit
- group
- plants
- extracts
- avocado
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
200528123 九、發明說明: 【發明所屬之技術領域】 本發明係有關一種有效及高安全性的脂酶阻礙劑,其Ab /、月匕 有效阻礙活體内負責脂質消化吸收之胰脂肪酶,及能抑制 和預防肥胖及高企脂症。 【先前技術】 伴隨體脂肪增加而來之肥胖及異常高值血清脂質的高腊 血症,係與高血壓、動脈硬化、糖尿病等的各種生活習慣 病的發病密切相關。肥胖的要因為體質因素、飲食因素、 精神因素、中樞性因素、代謝性因素、運動不足等,攝取 的卡路里超過消耗卡路里的結果,而造成脂肪蓄積。飲食 中的脂質中,三酸甘油酯係佔脂質的大部分,其由胰液中 的月曰轉分解成單醯甘油及游離脂肪酸而在小腸被吸收。於 是,認為可藉由阻礙此脂酶的作用而抑制來自飲食之脂質 的吸收,進而可抑制肥胖與高血脂症。 由於以上觀點,而積極進行尋求有優良脂酶阻礙活性成 分’亦即脂質吸收阻礙活性成分來自天然的成分。至今, 已有生畺、杜仲茶、白茶、綠茶、紅茶、烏龍茶、磷脂醯 膽驗、大豆蛋白、丹寧、牡丹根、黃蓮、黃柏、牡丹皮、 玄草、茶、苦蔘、甜椒、南瓜、姬菇、舞茸、藤木、毒活 (毋活,Radix Angelicae Pubespeneis)、良薑、檳榔子、揚 梅皮、決明子等被報告具有脂酶阻礙活性(專利文獻1、 2)。但是,並未獲得充分的效果。 [專利文獻1]日本特開2002-179586號公報 98334.doc 200528123 [專利文獻2]曰本特開2002-275077號公報 【發明内容】 因此,本發明目的在於提供有優良脂酶阻礙活性且安全 性高的脂酶阻礙劑。此外,本發明的目的也在於提供一種 脂質吸收阻礙劑、抗肥胖劑及高脂血症改善劑。 本發明者針對多種來自於天然植物的脂質阻礙作用努力 進行研究之結果,發現特定植物或其萃取物有優良的脂酶 阻礙作用及脂質吸收阻礙作用且有高安全性,因此而得以 完成本發明。 亦即本發明係提供自胳梨(Persea Americana Mill·)、紫 梅(Flacourtia inermis Roxb.)、蛋黃果(Pouteria campechiana Baehni)、肯氏蒲才兆(Eugenia jambolana Lam.)、 香果(Syzygium jambos (Linn.) Alston)及蓮霧(Szygium samarangense Merr & Perry)組成之群中選出一種以上的植 物或其萃取物作為有效成分之脂酶阻礙劑。 再者,本發明係提供以該等植物或其萃取物作為有效成 分之脂質吸收阻礙劑、抗肥胖劑及高脂血症改善劑。 此外,本發明係提供該等植物或其萃取物之用途,係用 於製造脂質吸收阻礙劑、抗肥胖劑及高脂血症改善劑者。 另外,本發明係提供一種脂質吸收阻礙方法、肥胖防止 方法及高脂血症改善方法,其係投與有效量之該等植物或 其萃取物。 本發明所使用之特定植物或其萃取物有脂質阻礙活性係 迄今所未知者,此係本發明首先獲得之創見。因而,該等 98334.doc 200528123 斗寸疋植物或其卒取物係有優良的脂酶阻礙活性而可作為脂 酶阻礙劑並以及脂質吸收阻礙劑、抗肥胖劑及高脂血症改 善劑極為有用。另外,該等特定植物或其萃取物亦可用作 為飲食品及化妝保養品,以抑制肥胖及高脂血症。此外, 由於該等特定植物或其萃取物係來自於天然,而可提供安 全性鬲的脂質吸收阻礙劑、抗肥胖劑及高脂血症改善劑 等。 ϋ 【實施方式】 於本發明中所使用之植物可列舉有··酪梨(persea Americana Mill·,樟科)、紫梅(Flac〇urtia inermis R〇xb, 大風子科)、蛋黃果(P〇uteria campechiana Baehni,山稅 科)、肯氏蒲桃(Eugenia jambolana Lam.,桃金孃科)、香 果(Szygium jamb〇s (Linn·) Alston,桃金孃科)及蓮霧 (Syzygium samarangense Merr & Perry,桃金孃科)。 該等植物萃取物除市售者外,亦可使用如後述般自植物 進行萃取操作而得者。 於本發明所使用之上述植物係可使用該植物之葉、莖、 芽、it*、木質部、木皮部(樹皮)等的地上部;根、塊莖等 的地下部,種子;果實;樹脂等全部部位。上述植物或其 萃取物中包含原植物、粉碎物(新鮮的或乾燥的)、榨汁、 粗萃取物、粗萃取物的純化物等全部。該等亦可單獨使 用’或者亦可兩種以上混合使用。 作為自上述植物獲得萃取物的萃取溶劑可舉例有甲醇、 乙醇、丙醇、丁醇等的低碳數醇類;乙酸乙酯等的酯類; 98334.doc 200528123 乙一醇、丁二醇、丙-赔 斗— 內一知、L3-丁二醇、丙三醇等多元醇 ;二乙醚、石油醚等醚類;丙酮、乙酸等的極性溶劑; 本、己烷、二甲苯等的烴類溶劑;生理食鹽水及水等。作 為萃取溶劑,較佳的有水或醇,尤以水為佳。該等萃取溶 制係可-種單獨使用或由兩種以上組合使用。 ,卞取方法可使用一般的方法,例如:將乾燥物或乾燥粉 碎物浸潰在溶劑中的方法,於常溫〜溶㈣點的溫度範圍 中二加溫料的方法等。所得萃取物依需要藉由過遽或離 、專除去固形物質後,就士古 、 ” 直接使用,或濃縮溶劑或亦可 乾燥後使用。 本發明最佳是藉由使溶劑萃取物減壓乾燥,再藉由真空 ^東乾燥等手段除去溶劑,再乾燥而作為植物萃取物之粗 乾燥物使用。 粗萃取物的純化可使用一 山 從用叙的方法,例如:使用活性 杈、矽膠、聚合物系載體等的 肌凌官柱層析法、液· /夜卒取法、分級沉澱等的方法。 如此所得之本發明特定植物或其萃取物有如同下述實施 不之優良脂酶阻礙活性’即可有效作為脂酶阻礙劑、 月曰質吸收阻礙劑、抗肥胖劑及高脂血症改盖南丨。 本發明之脂酶阻礙劑在使用於作Λ 讣馮月曰貝吸收阻礙劑、抗 肥胖劑及咼脂血症改善劑等的醫 永㈡况日寸,可使用經口投 卞或非經口投予之任一者,其可制 、版為旋劑、顆粒劑、散 d、膠囊、溶液劑、懸濁劑、乳劑 制1 … 冷,東乾燥劑等。該等 衣制可依製劑上常用方式調製。此外, π周衣如上述種種劑 98334.doc 200528123 型的醫藥製劑可依需要添加所希望的其他於藥學上容許的 載劑。例如··葡萄糖、乳糖、嚴糖、殿粉、甘露糖醇、糊 精、脂肪酸甘油酯、聚乙二醇、#呈乙基澱粉、乙二醇、聚 氧乙烯山梨糖醇酐脂肪酸酯、胺基酸、明膠、白蛋白、 水、生理食鹽水等之外’依f要可進而添加適宜的安定 劑、濕潤劑、乳化劑、結合劑、等張劑等的慣用200528123 IX. Description of the invention: [Technical field to which the invention belongs] The present invention relates to an effective and highly safe lipase inhibitor, which Ab /, dagger effectively block the pancreatic lipase in vivo responsible for lipid digestion and absorption, and can Inhibit and prevent obesity and high fat. [Prior art] Obesity and abnormally high serum lipid-associated hyperlipidemia accompanying increased body fat are closely related to the onset of various lifestyle diseases such as hypertension, arteriosclerosis, and diabetes. Obesity is due to physical factors, dietary factors, mental factors, central factors, metabolic factors, insufficient exercise, etc., and the calorie intake exceeds the result of calorie consumption, resulting in fat accumulation. Among the lipids in the diet, triglycerides account for most of the lipids. They are decomposed into mono-glycerol and free fatty acids by the month of the pancreatic juice and absorbed in the small intestine. Therefore, it is thought that by inhibiting the action of this lipase, it is possible to suppress the absorption of lipids from the diet, thereby suppressing obesity and hyperlipidemia. In view of the foregoing, active search for an excellent lipase-inhibiting active ingredient ', that is, a lipid-absorption-inhibiting active ingredient is derived from a natural ingredient. So far, there have been raw coriander, eucommia ulmoides tea, white tea, green tea, black tea, oolong tea, phospholipid test, soy protein, tannin, peony root, yellow lotus, cork, peony peel, black grass, tea, bitter pepper, sweet pepper , Pumpkin, shimeji mushroom, maitake mushroom, rattan, poisonous (Radix Angelicae Pubespeneis), ginger, betel nut, Yangmeipi, Cassia, etc. have been reported to have lipase inhibitory activity (Patent Documents 1, 2). However, sufficient results were not obtained. [Patent Literature 1] Japanese Patent Laid-Open No. 2002-179586 98334.doc 200528123 [Patent Literature 2] Japanese Patent Laid-Open No. 2002-275077 [Summary of the Invention] Therefore, the present invention aims to provide an excellent lipase inhibitory activity and to be safe Sexual lipase inhibitor. It is another object of the present invention to provide a lipid absorption inhibitor, an anti-obesity agent, and a hyperlipidemia improving agent. The present inventors have conducted research on a variety of lipid blocking effects from natural plants and found that specific plants or their extracts have excellent lipase blocking effects and lipid absorption blocking effects and have high safety, and thus completed the present invention . That is, the present invention is provided by Persea Americana Mill ·, Flacurtia inermis Roxb., Pouteria campechiana Baehni, Eugenia jambolana Lam., And Syzygium jambos (Linn.) Alston) and lotus mist (Szygium samarangense Merr & Perry) selected more than one plant or its extract as an active ingredient lipase inhibitor. Furthermore, the present invention provides a lipid absorption inhibitor, an anti-obesity agent, and a hyperlipidemia improving agent using these plants or their extracts as effective ingredients. In addition, the present invention provides the use of these plants or their extracts, and is used for the production of lipid absorption inhibitors, anti-obesity agents, and hyperlipidemia improvers. In addition, the present invention provides a method for inhibiting lipid absorption, a method for preventing obesity, and a method for improving hyperlipidemia by administering an effective amount of these plants or their extracts. The specific plant or its extract used in the present invention has a lipid-blocking activity system which has not been known so far. This is the first invention obtained by the present invention. Therefore, these 98334.doc 200528123 Dougian plants or their extracts have excellent lipase inhibitory activity and can be used as lipase inhibitors, as well as lipid absorption inhibitors, anti-obesity agents, and hyperlipidemia improvers. it works. In addition, these specific plants or their extracts can also be used as food and drink and cosmetics to suppress obesity and hyperlipidemia. In addition, since these specific plants or their extracts are derived from natural sources, they can provide lipid-absorption inhibitors, anti-obesity agents, and hyperlipidemia improvers for safety.实施 [Embodiment] The plants used in the present invention include avocado (persea Americana Mill, Camphoraceae), purple plum (Flacourtia inermis Roxb), egg yolk fruit (P 〇uteria campechiana Baehni (Shanxi Branch), Eugenia jambolana Lam., Szygium jambos (Linn ·) Alston, Syzygium samarangense Merr & Perry). These plant extracts can also be obtained by performing extraction operations from plants as described below, in addition to commercially available ones. In the above-mentioned plant system used in the present invention, the above-ground parts of the leaves, stems, buds, it *, xylem, veneer (bark), etc. of the plant; the roots, tubers, etc., seeds, fruits, resin, etc. Parts. The above plants or their extracts include the original plants, pulverized products (fresh or dried), juice extracts, crude extracts, and purified products of crude extracts. These may be used singly 'or in combination of two or more kinds. Examples of the extraction solvent obtained from the above-mentioned plants include low-carbon alcohols such as methanol, ethanol, propanol, and butanol; esters such as ethyl acetate; 98334.doc 200528123 ethylene glycol, butanediol, and propylene -Battle — Polyols such as Uchiichi, L3-butanediol, glycerol; ethers such as diethyl ether and petroleum ether; polar solvents such as acetone and acetic acid; hydrocarbon solvents such as benzine, hexane and xylene ; Physiological saline and water. As the extraction solvent, water or alcohol is preferred, and water is particularly preferred. These extractive dissolving systems may be used singly or in combination of two or more. For the extraction method, a general method can be used, for example, a method of immersing a dried substance or dried powder in a solvent, and a method of adding a warmer in a temperature range from normal temperature to the melting point. The obtained extract can be used directly after removing the solid matter by dehydration or ionization, or used directly, or the solvent can be concentrated or used after drying. The present invention is best performed by drying the solvent extract under reduced pressure. Then, the solvent is removed by means of vacuum drying, and then dried to be used as a crude dried product of the plant extract. The purification of the crude extract can be carried out using the method described in the application, such as: using active branches, silicone, polymerization Methods such as muscle column chromatography, liquid / night extraction, fractional precipitation, etc. of the carrier, etc. The specific plant of the present invention or the extract thereof obtained as described above may have excellent lipase inhibitory activity as described below. Effectively used as a lipase inhibitor, an anti-obesity agent, an anti-obesity agent, and a hyperlipidemia remedy. The lipase inhibitor of the present invention is used as an anti-obesity agent for anti-obesity and anti-obesity Medicines and lipemia improvement agents, etc. can be used daily, can be used either orally or parenterally, it can be made, plate, spinner, granules, powder, capsules , Solution, suspension 1 、 Emulsion system 1 ... Cold, Dong desiccant, etc. These clothing systems can be prepared according to the usual methods in preparation. In addition, π week clothing such as the above-mentioned various agents 98334.doc 200528123 type pharmaceutical preparations can be added with other desired Pharmaceutically acceptable carriers. For example ... glucose, lactose, sugar, gluten powder, mannitol, dextrin, fatty acid glycerides, polyethylene glycol, #ethyl starch, ethylene glycol, polyoxyethylene sorbitan In addition to sugar alcohol anhydride fatty acid esters, amino acids, gelatin, albumin, water, physiological saline, etc., appropriate stabilizers, wetting agents, emulsifiers, binding agents, isotonic agents, etc. may be added as necessary. Idiomatic
本發明植物或其萃取物亦可配合飲食品使用。在此,所 謂的飲食品係直接添加上述植物或其萃取物或添加種種營 養成刀《於I人艮口口中含有該等物質,而可作為對治療及 預防肥胖與高脂血症有㈣保健食品或食品素材者。該等 飲艮口口的型恶可列舉有··於有效成分中添加慣用助劑之顆 粒狀、粒狀、鍵劑、膠囊、糊劑等的型態。此外,亦可於 火腿、香腸等的肉類加工食品;魚板、魚捲等的水產加工 食品;麵包、糕點、奶油、奶粉、發酵乳製品等的食品, 或水'果汁、牛奶、清涼飲料等的飲料中添加而使用。The plant or the extract thereof can also be used in combination with food and beverage. Here, the so-called food and beverage line directly adds the above plants or their extracts or adds various nutrients into the knife. "I contain these substances in the mouth of I Rengen, and it can be used as a health care for the treatment and prevention of obesity and hyperlipidemia." Food or food material. Examples of these types of stigma include: granules, granules, bonding agents, capsules, pastes and the like in which conventional additives are added to the active ingredients. In addition, it can also be used in processed meats such as ham and sausages; aquatic processed foods such as fish plates and fish rolls; foods such as bread, cakes, cream, milk powder, fermented dairy products, or water 'juices, milk, refreshing drinks, etc. Used in beverages.
本發明之植物或其萃取物的有效投+量係依患者年齡、 :重、症狀、患者病況、投予路徑、投藥週期、製劑型 悲、素材阻礙活性之強度等而適宜地決$,例如、經口投予 萃取物時’以乾燥重量換算…般每天較佳為請卜咖 么克“斤體重。為蓮霧(Syzygium samarangense Merr &The effective dosage + amount of the plant or its extract of the present invention is appropriately determined according to the patient's age, weight, symptoms, patient condition, route of administration, administration cycle, formulation type, intensity of material blocking activity, etc., such as 2. When the extract is administered orally, 'based on dry weight conversion ... Generally, it is better to ask Bokamoke's weight per day. For Syzygium samarangense Merr &
Peiry)的熱水萃取物的時候,以乾燥重量換算,特別是每 天車父佳為5〜300毫克/公斤體重。 此外’本發明之植物或其萃取物亦可使用作為含有脂酶 阻礙劑的化妝保養品或化妝保養品的素材。例如,於小麥 98334.doc -10- 200528123 胚芽油或撖欖油中添加本發明植物之乾燥 κ 成為含有脂酶阻礙劑的組成物,再將其作為化妝:::而 素材。本發明植⑮或其萃取物的添 /、…的 曰y , 里卫未特別限制,但 例如相對於小麥胚芽油或撖檀油,以乾燥重量ρ, 較佳為0.1〜60重量%以下,特別佳為〇·5〜5〇重量%。、斤 使用上述含有脂酶阻礙劑組成物作為化妝保養品成分, 在製成化妝保養品時,可用各種型態,例如:乳液,化 液、面霜、護手霜、化妝水、精華液、洗髮精、潤 等。上述的化妝保養品可依常法製造。或者,化妝保養品 j分可與一般使用的助劑任意組合使用。本發明植物或其 萃取物的添加量以乾燥重量換算,較佳是化妝保養品總重 量的0.01-20重量%。 於本發明中所使用的植物由於來自於天然,因此其毒性 低,例如即使對大白鼠經口投予蓮霧(Syzygi疆 samarangense Merr & Peiry)的熱水萃取物,以每日1〇〇〇毫 克/公斤,歷經100天的長時間,結果亦無確認死亡例,亦 未觀察到有體重的變化。 實施例 以下係列舉實施例以更具體的說明本發明,但是,本發 明並未被限定於該等實施例。 實施例1 (1)萃取植物 於各 10 克的胳梨(Persea Americana Mill.)、紫梅 (Flacourtia inermis Roxb·)、蛋黃果(Pouteria campechiana 98334.doc -11- 200528123Peiry) hot water extract, in terms of dry weight, especially 5 ~ 300 mg / kg body weight per day. In addition, the plant or its extract of the present invention can also be used as a cosmetic or cosmetic product containing a lipase inhibitor. For example, the dried κ of the plant of the present invention is added to wheat 98334.doc -10- 200528123 germ oil or olive oil to become a composition containing a lipase inhibitor, which is then used as a makeup ::: material. The y, y, y, y, y, y of phytocarp or its extract according to the present invention are not particularly limited, but, for example, relative to wheat germ oil or sandalwood oil, the dry weight ρ is preferably 0.1 to 60% by weight, It is particularly preferably from 0.5 to 50% by weight. 2. Use the above lipase inhibitor-containing composition as a cosmetic product. When making cosmetic products, you can use various types, such as: lotion, liquid, cream, hand cream, lotion, essence, wash Hair fine, moisturizing, etc. The above-mentioned cosmetic products can be manufactured according to a conventional method. Alternatively, the cosmetics j may be used in any combination with commonly used auxiliaries. The added amount of the plant or the extract thereof according to the present invention is calculated on a dry weight basis, preferably 0.01 to 20% by weight based on the total weight of the cosmetic product. The plant used in the present invention has low toxicity because it is derived from nature. For example, even if a rat is administered orally with a hot water extract of lotus fog (Syzygi samarangense Merr & Peiry), it is 100% daily. 〇mg / kg over a long period of 100 days, no deaths were confirmed and no change in body weight was observed. Examples The following series of examples illustrate the present invention in more detail, but the present invention is not limited to these examples. Example 1 (1) Extraction of plants: 10 grams each of Pear (Persea Americana Mill.), Purple Plum (Flacourtia inermis Roxb.), And Yolk Fruit (Pouteria campechiana 98334.doc -11- 200528123)
Baehm)、肯氏蒲桃(Eugenia jamb〇iana Lam )、香果 (Szygmm jambos (Lmn·) Alston)及蓮霧(巧2旭咖 samarangense Merr & Perry,桃金孃科)中添加2〇〇毫升的蒸 餾水,於100 °C煮沸30分鐘後,冷凍乾燥,獲得各熱水萃 取乾燥物。 (2)脂酶阻礙活性試驗 脂酶阻礙活性測定是使用豬胰脂酶(Sigma公司製)及大 曰本製藥製的「脂酶套組S」。測定方法係部分改變製造者 的說明書而進行。亦即,在150微升的含萃取物試劑樣品 中加入40微升酵素溶液(0 05毫克/毫升豬騰脂酶、125毫莫 耳/升Tds鹽酸(PH 7.5))、500微升之呈色液(含〇·!毫克/毫 升5,5’-二硫代雙(2-硝基苯甲酸)之緩衝液),混合後,於 °C預熱5分鐘,加入5〇微升基質液(6·69毫克/毫升三丁酸二 硫酵+5.73毫克/毫升十二烷基硫酸鈉),混合後,於遮光 下,在30 C反應30分鐘。之後,添加1毫升反應停止液以 止反應。空白組係添加試劑樣品溶液、酵素溶液、呈色 液’於30°C下加熱5分鐘,於遮光下在30°c加熱3〇分鐘, 添加反應停止液後添加基質液。於412毫微米波長測定各 個樣品的吸光度。用以下的公式算出脂酶阻礙活性。 (數學式1) 脂酶阻礙活性=100-(AT-ABT)/(AC-ABC)x100(〇/〇) AT :試劑樣品的吸光度 ABT :試劑樣品之空白組吸光度 AC :盲檢用樣品的吸光度 98334.doc 200528123 ABC :盲檢用樣品之空白組吸光度 比較例1 對大花紫薇(banaba)、迷迭香(rosemary)、番石榴 (guava)、羅布麻(lafuma)、如意波斯(rooibos)、檳榔子、 甜胡椒(allspice)、小連魅、豆茶決明、山椒、匙羹藤、杜 仲、刺五加、山楂、人參、貫葉金絲桃、檸檬香茅、貓爪 草、茉莉、薑、蛇麻草(h〇p)、山茱萸、山扁豆、西洋人 參、小麥、石鹼草、薏仁、決明子、蘋果、南瓜、雪蓮 (yacon)、牡丹根、苦楝、匙羹藤、人參果亦進行同樣的試 驗。 於表Uf不各熱水萃取物之脂酶阻礙活性之測定結果。 本發明之絡举、砂始 m 务、梅、蛋貫果、肯氏蒲桃、香果及蓮霧 之任一者各具有高脂酶阻礙活性。Baehm), Eugenia jambiana Lam, Szygmm jambos (Lmn.) Alston, and lotus mist (Samarangense Merr & Perry, Myrtle) The milliliter of distilled water was boiled at 100 ° C for 30 minutes, and then freeze-dried to obtain each hot-water extracted dried product. (2) Lipase inhibitory activity test The lipase inhibitory activity was measured using porcine pancreatic lipase (manufactured by Sigma) and "lipase kit S" manufactured by Daiichi Pharmaceutical. The measurement method was performed by partially changing the manufacturer's instructions. That is, 150 microliters of the extract-containing reagent sample was added with 40 microliters of an enzyme solution (0.05 mg / ml porcine lipase, 125 millimoles per liter of Tds hydrochloric acid (pH 7.5)), and 500 microliters of Color solution (buffer containing 0.5 mg / ml 5,5'-dithiobis (2-nitrobenzoic acid)), after mixing, preheat at 5 ° C for 5 minutes, and add 50 microliters of matrix solution (6.69 mg / ml tributyric acid disulfide + 5.73 mg / ml sodium dodecyl sulfate), after mixing, react at 30 C for 30 minutes under light. Thereafter, 1 ml of a reaction stop solution was added to stop the reaction. The blank group was added with a reagent sample solution, an enzyme solution, and a coloring solution 'and heated at 30 ° C for 5 minutes, and heated at 30 ° C for 30 minutes under light, and the reaction solution was added with a matrix solution. The absorbance of each sample was measured at a wavelength of 412 nm. The lipase inhibitory activity was calculated using the following formula. (Mathematical formula 1) Lipase inhibitory activity = 100- (AT-ABT) / (AC-ABC) x100 (〇 / 〇) AT: absorbance of reagent sample ABT: absorbance of blank group of reagent sample AC: of blind sample Absorbance 98334.doc 200528123 ABC: Comparative Example of Absorptivity of the Blank Group of the Sample for Blind Examination 1 Pair of lavender (banaba), rosemary (guava), guava (lafuma), rooibos (rooibos) , Betel nut, allspice, xiaolianmei, cassia cassia, pepper, sagebrush, eucommia ulmoides, acanthopanax senticosus, hawthorn, ginseng, hypericum perforatum, lemongrass, cat's claw, jasmine, ginger , Hop (hop), dogwood, mangosteen, American ginseng, wheat, lycorrhiza, coix seed, cassia seed, apple, pumpkin, snow lotus (yacon), peony root, bitter tincture, spoon vine, ginseng fruit test. Table Uf shows the results of lipase inhibitory activity of each hot water extract. Each of the present invention's complex, samura, plum, egg fruit, Kennedy rose apple, fragrant fruit, and lotus mist each has a high lipase inhibitory activity.
98334.doc 13- 200528123 [表i] 植物萃取物 脂酶阻礙活性 (IC5G毫克/毫升) 實施例1 蓮霧 0.13 香果 0.15 肯氏蒲桃 0.26 蛋黃果 0.31 紫梅 0.33 酪梨 0.38 比較例1 大花紫薇 0.56 迷迭香 0.57 番石榴 0.69 羅布麻 0.71 如意波斯 0.84 檳榔子 0.98 甜胡椒 1.03 小連赵 1.04 豆茶決明 1.26 山椒 1.30 匙羹藤 >1.43 杜仲 >1.43 刺五加 >1.43 山楂 >1.43 人參 >1.43 貫葉金絲桃 >1.43 檸檬香茅 >1.43 貓爪草 >1.43 茉莉 >1.43 薑 >1.43 蛇麻卓 >1.43 山茱萸 >1.43 山扁旦 >1.43 西洋人參 >1.43 小麥 >1.43 石驗卓 >1.43 薏仁 >1.43 決明子 >1.43 蘋果 >1.43 南瓜 >1.43 雪蓮 >1.43 牡丹根 >1.43 苦楝 >1.43 匙羹藤 >1.43 人參果 >1.43 98334.doc -14- 200528123 實施例2 (1)植物的萃取 依實施例之相同方法,由各1〇克之蛋黃果(P〇uteda campechiana Baehni)、肯氏蒲桃(EUgenia jamb〇iana Lam.) 、連霧(Syzygium samarangense Meir & Perry)得各熱水萃取 乾燥物。 (2)脂質吸收阻礙活性試驗98334.doc 13- 200528123 [Table i] Plant extract lipase inhibitory activity (IC5G mg / ml) Example 1 Lotus mist 0.13 Bergamot 0.15 Kent's rose apple 0.26 Yolk fruit 0.31 Purple plum 0.33 Avocado 0.38 Comparative example 1 large Flower Lagerstroemia 0.56 Rosemary 0.57 Guava 0.69 Apocynum 0.71 Ruyi Persian 0.84 Betel Nut 0.98 Sweet Pepper 1.03 Xiaolian Zhao 1.04 Bean Tea Cassia 1.26 Japanese Pepper 1.30 Spoon Vine > 1.43 Eucommia ulmoides > 1.43 Acanthopanax sentifolium > 1.43 Hawthorn > 1.43 Ginseng > 1.43 St. John's wort, > 1.43 Lemongrass > 1.43 Cat's claw, > 1.43 Jasmine > 1.43 Ginger > 1.43 Hopper > 1.43 Dogwood > 1.43 Mountain Flat > 1.43 Western Ginseng > 1.43 Wheat > 1.43 Stone Test > 1.43 Coix Seeds > 1.43 Cassia Seeds > 1.43 Apple > 1.43 Pumpkin > 1.43 Snow Lotus > 1.43 Peony Root > 1.43 Melia > 1.43 Spoon Ginseng > 1.43 Ginseng Fruit > 1.43 98334.doc -14- 200528123 Example 2 (1) Extraction of plants According to the same method as in the example, 10 grams of egg yolk fruit (Potauteda campechiana Baehni), EUgenia jamaiana Lam., and Syzygium samarangense Meir & Perry) to obtain dried extracts of each hot water. (2) Lipid absorption hindering activity test
對已禁食24小時之ICR小鼠(雄性,6〜7週齡)每隻於胃户 強制投予200微升之撖欖油作為對照組。另一方面,實塌 組係以撖欖油混合各熱水萃取乾燥物成1〇〇毫克/毫升之讀 度,每隻小鼠於胃内強制投予2〇〇微升。於強制投予前及 投予後1、2、3、6個小時之各時點從尾靜脈採血,經離心 付血清。使用和光純藥的「giyceride G Test Wako」測定 血清中的三酸甘油酯。以時間為橫軸,血清三酸甘油酿遺 ^為縱軸作B,由所得曲線求得該曲線下之面積,作為脂 質吸收阻礙活性的指標。脂質阻礙活性係將對照組曲線; 7、貝乍為1 〇〇,以各貫驗組的曲線下之面積之相對值表 比較例2 對大化紫薇、綠茶亦進行相同的試驗。 於表2顯示各熱水萃取物之脂質吸收阻礙活性的測定結 本發明之蛋黃果、蓮霧、 吸收阻礙活性。 肯氏蒲桃之萃取物均有高脂質 98334.doc -15 - 200528123 [表2] 植物萃取物 與對照組之比氺 實施例2 蛋黃果 51 蓮霧 52 肯氏蒲桃 76 比較例2 大花紫薇 88 綠茶 89 --__ *以對照組曲線下的面積當為100 處方例1 以下述處方混合各種成分,經造粒、乾燥、整粒後,將 其打錠而製造成錠劑。 (處方) 肯氏蒲桃萃取物(實施例1) 40 毫克 微結晶纖維素 100 乳糖 80 硬脂酸鎂 0.5 甲基纖維素 12 處方例2 藉由下述處方’依一般方法配合各成分而獲得均質化之 ’月/尽飲料。所得清>:了、飲料填充於褐色觀子後,以紹羯蓋封 瓶,施以加熱處理。該等飲料外觀及風味均良好。 (處方) 蓮霧萃取物(實施例1) 〇 · 8克 98334.doc 16- 200528123 香料 0.8 水 100 還原澱粉糖化物 24 果糖 18 處方例3 藉由下述處方,依一般方法配合各成分而獲得均質化之 面霜。 (處方) 異硬脂酸異丙酯 8.0重量% 荷荷巴油 6.0 蘇蝶醇 8.0 硬脂醇 2.0 聚氧乙烯月桂基醚 1.5 丙二醇 6.0 山梨糖醇 1.0 對羥基苯甲酸酯 0.4 香果萃取物(實施例1) 0.5 維生素E 0.5 香料 0.1 水 66.0ICR mice (male, 6 to 7 weeks old) who had been fasted for 24 hours were forcibly given 200 microliters of olive oil as a control group. On the other hand, the collapse group was mixed with hot water to extract dried matter at a concentration of 100 mg / ml, and each mouse was forcibly administered with 200 microliters in the stomach. Blood was collected from the tail vein before compulsory administration and at 1, 2, 3, and 6 hours after administration, and the serum was centrifuged. The "giyceride G Test Wako" of Wako Pure Chemicals was used to measure triglycerides in serum. Taking time as the horizontal axis and serum triglycerol production as the vertical axis as B, the area under the curve was obtained from the obtained curve as an indicator of lipid absorption inhibiting activity. The lipid-blocking activity is the curve of the control group; 7. Becha is 100, and the relative value of the area under the curve of each test group is compared. Comparative Example 2 The same test was performed on Lagerstroemia indica and green tea. Table 2 shows the measurement results of lipid absorption inhibiting activity of each hot water extract. The yolk fruit, lotus mist, and absorption inhibiting activity of the present invention are shown. The extracts of K. rosemary have high lipids. 98334.doc -15-200528123 [Table 2] The ratio of plant extracts to the control group. Example 2 Yolk fruit 51 Lotus mist 52 K. rosemary 76 Comparative example 2 Large flowers Lagerstroemia indica 88 green tea 89 --__ * The area under the curve of the control group is 100. Prescription Example 1 The ingredients are mixed according to the following prescription, granulated, dried and granulated, and then tableted to make a tablet. (Recipe) Kent's Rosehip Extract (Example 1) 40 mg of microcrystalline cellulose 100 lactose 80 magnesium stearate 0.5 methyl cellulose 12 Formulation Example 2 Obtained by formulating the ingredients according to the general method below Homogeneous 'Month / Drink'. The resulting clear >: After the beverage was filled in brown guanzi, the bottle was capped with Shaoyu and subjected to heat treatment. These beverages have good appearance and flavor. (Prescription) Lotus mist extract (Example 1) 0.8 g 98334.doc 16- 200528123 Flavor 0.8 Water 100 Reduced starch saccharification 24 Fructose 18 Formulation Example 3 According to the following formulation, each component is obtained by the general method. A homogenized cream. (Prescription) isopropyl stearate 8.0% by weight jojoba oil 6.0 sterol 8.0 stearyl alcohol 2.0 polyoxyethylene lauryl ether 1.5 propylene glycol 6.0 sorbitol 1.0 parabens 0.4 fragrant fruit extract (Example 1) 0.5 Vitamin E 0.5 Fragrance 0.1 Water 66.0
98334.doc 1798334.doc 17
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003416505 | 2003-12-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200528123A true TW200528123A (en) | 2005-09-01 |
Family
ID=34675163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093138957A TW200528123A (en) | 2003-12-15 | 2004-12-15 | Lipase inhibitor |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2005056031A1 (en) |
TW (1) | TW200528123A (en) |
WO (1) | WO2005056031A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1902723B1 (en) * | 2006-09-19 | 2009-07-08 | Jürgen Prof. Dr. Schrezenmeir | Sabal fruit or Sabal oil as lipase inhibitor |
JP5999957B2 (en) * | 2012-03-30 | 2016-09-28 | 株式会社 資生堂 | APJ activator |
GB2531252A (en) * | 2014-10-13 | 2016-04-20 | Thiru Sethukkarai | Indian herbal liquids for treating lung infection and blood purification and preparation method thereof |
JP6763114B2 (en) * | 2016-06-02 | 2020-09-30 | 国立大学法人 琉球大学 | PARP inhibitors containing Ooftomomo extract |
EP3552616B1 (en) * | 2018-04-09 | 2021-12-29 | MHBT Co., Ltd. | Hydrolysate of water extract of syzygium samarangense, and preparation process and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4047441B2 (en) * | 1998-03-05 | 2008-02-13 | 株式会社資生堂 | Lipid degradation promoter and slimming skin external preparation |
JP2001122732A (en) * | 1999-10-26 | 2001-05-08 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing moisturizing plant extract |
JP4693964B2 (en) * | 2000-08-07 | 2011-06-01 | カゴメ株式会社 | New antifeedant |
-
2004
- 2004-12-14 JP JP2005516227A patent/JPWO2005056031A1/en active Pending
- 2004-12-14 WO PCT/JP2004/018618 patent/WO2005056031A1/en active Application Filing
- 2004-12-15 TW TW093138957A patent/TW200528123A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005056031A1 (en) | 2005-06-23 |
JPWO2005056031A1 (en) | 2007-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3966689B2 (en) | Lipase inhibitor | |
JP2004075638A (en) | Functional material having action to suppress increase of blood sugar level and suppress increase of blood pressure | |
CN103747794A (en) | Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis | |
JP2003192605A (en) | Lipase inhibitant | |
JP3768795B2 (en) | Xanthine oxidase inhibitor | |
JP6631877B2 (en) | Anti-aging agent | |
KR101394358B1 (en) | Health composition relieving alcohol hangover | |
KR102137136B1 (en) | Composition comprising pumpkin hydrolysis extract, amorphophallus paeoniifolius hydrolysis extract, curcuma extract and cacao nibs extract | |
KR20160081205A (en) | Composition comprising extract of hydrangea serrata for preventing and improving obesity | |
EP1369123A1 (en) | A health-care product comprising lotus rhizome and process for its preparation | |
TW200528123A (en) | Lipase inhibitor | |
JP2001163795A (en) | alpha-GLUCOSIDASE INHIBITOR | |
KR101525877B1 (en) | A composition for preventing wrinkle of skin and anti aging of skin | |
KR101821925B1 (en) | A composition comprising the complex extract of Poncirus trifoliata and Cinnamommum cassia for treating or preventing allergy desmatitis | |
KR20200061285A (en) | Food Composition for blood circulation and for Preventing blood vessel disease Comprising Extract of Galangal | |
JP2004352626A (en) | Anticholesterol agent containing plant-derived component | |
KR101479096B1 (en) | Health functional food comprising extracts of herbal mixture for preventing or improving edema of delivered or pregnant woman | |
KR101738206B1 (en) | A composition comprising the complex extract of Poncirus trifoliata and Cinnamommum cassia for treating or preventing allergy desmatitis | |
JP2004323439A (en) | Composition for ameliorating blood viscosity | |
KR100642801B1 (en) | Anti-diabetic food composition comprising extracts from natural herbal materials and pear and process for preparing the same | |
KR101154031B1 (en) | Composition for Antifati gue containin g herbal mixture extract as in gredient compounds | |
JP2006016340A (en) | Blood uric acid level reduction agent having extract of punica granatum l. as active ingredient | |
WO2004019962A1 (en) | Hair growth stimulants for oral use | |
TW201927326A (en) | Method for producing fermentation product derived from green tea extract, and koji fermentation product derived from green tea extract | |
Mittal et al. | MAHUA (MADHUCA LONGIFOLIA, SAPOTACEAE): A REVIEW OF ITS PROPERTIES AND EFFECTS |